Low prices could come from either a) a robust, competitive market in producing and selling insulin or b) governmental price controls. The USA explicitly chooses not to have either. Other countries typically choose b) backed up by a threat of a) (if you're a pain in the ass over our negotiated price controls, we'll go source a large supply of insulin from somewhere else).